Phentermine is classified as a Schedule IV controlled substance due to its amphetamine-like structure and potential for dependence
Ozempic (semaglutide) is a brand-name drug approved by the Food and Drug Administration (FDA) for the following uses: to help manage blood sugar levels in people with type 2 diabetes, along with diet and exercise to reduce the risk of heart attack and stroke in adults with type 2 diabetes and cardiovascular disease to reduce the risk of complications from chronic kidney disease in adults with type 2 diabetes A doctor may also prescribe Ozempic off-label for weight loss, though the FDA has not approved it for this use
Risk rises when factors accumulate, for example dose escalation, timing near large meals, existing reflux, or diabetic neuropathy, and a small subset of users, about 1 in 50 (2%), report persistent hiccups that need clinical attention
Ongoing Care and Accountability Regular follow-up appointments are essential for your safety and success
This energy deficit, while promoting weight loss, can result in fatigue, lightheadedness, and generalized weakness, particularly during the initial weeks of treatment or after dose escalation
Reduction in HbA1c levels
